Evidence map›Paper›PMID 41839686›Full record

ArticleJournal, genetic engineering & biotechnology2026

Surface-bioengineering of bacteriophage AP205 and MS2 virus-like particles with novel Spytag003 for antigen conjugation.

Hong Liu, Ebenezer Tumban

Abstract read
In one paragraph

Article in Journal, genetic engineering & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hong LiuGraduate Program in One Health Sciences, School of Veterinary Medicine, Texas Tech University, Amarillo, TX 79106, USA.
Ebenezer TumbanGraduate Program in One Health Sciences, School of Veterinary Medicine, Texas Tech University, Amarillo, TX 79106, USA. Electronic address: etumban@ttu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The insertion of foreign antigens on the coat protein of viruses sometimes interferes with the ability of the coat proteins to assemble into virus-like particles (VLPs). To overcome this limitation, Spytag/Spycatcher bio-conjugation system was developed; however, the conjugation system has pre-existing antibodies that makes it less desirable for vaccine applications. Recently, a novel bio-conjugation system, Spytag003/Spycatcher003, was developed to by-pass this problem. The ability of this new bio-conjugation system to be used to displayed foreign antigens on VLPs has never been explored. Here we assessed whether the insertion of Spytag003 on the coat proteins of AP205 and MS2 would interfere with the ability of the coat proteins to assemble into VLPs. We showed that the insertion of Spytag003 on the N-termini of coat proteins of AP205 and MS2 did not affect their ability to assemble into VLPs. Optimized purification yielded VLPs with high purity, which were successfully conjugated with Spycatcher003 and Ag2/PRA-CSA protein. Mice immunized with the conjugated Spycatcher003 protein elicited high-titer IgG antibodies compared to immunization with unconjugated protein. However, immunization with Ag2/PRA-CSA conjugated or unconjugated to Spytag003-tagged VLPs did not have a significant difference in antibody responses between the two groups. Overall, our results show that the N-termini of AP205 and MS2 are more tolerant to Spytag003 insertions and can be used to conjugate a foreign antigen; as a proof-of-concept, we conjugated a prototype antigen, Ag2/PRA-CSA, on the VLPs. The potential to conjugate diverse antigens on these novel bio-engineered platforms should be explored further.

Indexed as

AP205Bio-conjugationImmunizationMS2Spycatcher003Spytag003VaccineVLPs

Identifiers

PMID41839686
PMCPMC12919298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.